Internet-delivered Cognitive Behavior Therapy for Atrial Fibrillation
21 сентября 2020 г. обновлено: Brjann Ljotsson, Karolinska Institutet
Internet-delivered Cognitive Behavior Therapy for Atrial Fibrillation - a Randomized Controlled Trial
The aim is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF) compared to treatment as usual.
The study will include 120 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.
Обзор исследования
Статус
Завершенный
Условия
Подробное описание
Atrial fibrillation (AF) is the most common cardiac arrhythmia (irregular heartbeat) affecting 3% of the population. AF is associated with poor quality of life (QoL) and large costs for society. In a considerable proportion of patients, AF symptoms (e.g., palpitations, fatigue, and chest pain) are not alleviated by current medical or interventional treatments. Psychological factors can worsen AF symptoms, and anxiety and depression are common among AF patients. Symptom preoccupation and avoidance of social and physical activities are likely to play important roles in the development of anxiety, depression, disability and healthcare utilization.
The aim is to evaluate if CBT, based on behavioral activation and exposure principles, improves wellbeing and QoL in symptomatic AF patients more than a wait list offered treatment as usual.
Method: A randomized controlled trial. Participants are randomized to internet-delivered CBT for 10 weeks (N=60) or to treatment as usual (N=60). The internet-delivered CBT-program will last for 10 weeks and include weekly therapist support, consisting of online messages and telephone calls. Patients on the treatment as usual wait list will be provided standardized written information about basic self-management in AF. The treatment as usual wait list will be crossed over to treatment 3 months after the treatment group has completed treatment.
Тип исследования
Интервенционный
Регистрация (Действительный)
126
Фаза
- Непригодный
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
-
Stockholm, Швеция
- Karolinska Universitetssjukhuset Solna
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
От 18 лет до 75 лет (Взрослый, Пожилой взрослый)
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Все
Описание
Inclusion Criteria:
- Inclusion criteria: A) Paroxysmal AF ≥ once per month that causes moderate to severe symptoms and leads to significant distress or interferes with daily life (i.e. EHRA class ≥ IIb) ; B) Age 18-75 years; C) On optimal medical treatment; D). Able to read and write in Swedish.
Exclusion Criteria:
- (E) heart failure with severe systolic dysfunction (ejection fraction ≤ 35%); (F) significant valvular disease; (G) planned ablation for AF or ablation within 3 months before assessment; (H) other severe medical illness; (I) any medical restriction to physical exercise; (J) severe psychiatric disorder, severe depression, or risk of suicide; (K) alcohol dependency.
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Назначение кроссовера
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Internet-delivered CBT over 10 weeks
The CBT treatment lasts for 10 weeks and includes the following: Education on the role of anxiety on cardiac function and the effects of symptom preoccupation and avoidance QoL and depression in AF, creating a vicious cycle; exposure to physical sensations that are similar to AF symptoms (e.g.,palpitations due to physical activity or stress) to reduce fear of these symptoms; exposure to situations or activities previously avoided and abolishment of behaviors that aim to control symptoms; and behavioral activation aiming to increase social and physical activity and reduce depressive symptoms.
Therapist support is provided at least once weekly through the platform developed for the purpose.
Therapists are trained CBT-psychologists.
|
The intervention lasts for 10 weeks and include: Education, Interoceptive exposure, exposure in-vivo, combining in-vivo exposure with interoceptive exposure, behavioral activation and relapse prevention.
Include the guidance of a minimum weekly contact with a CBT psychologist.
|
|
Плацебо Компаратор: Treatment as usual wait list
Patients randomized to the treatment as usual wait list arm will receive standardized AF information that emphasizes that an active physical and social lifestyle is necessary to maintain good health.
Thus, the treatment as usual arm will control for the provision of basic patient information, but without the guidance of a psychologist or any CBT interventions.
|
Consist of standardized AF information that emphasizes that an active physical and social lifestyle is necessary to maintain good health, without the guidance of a psychologist or any CBT interventions.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
The Atrial Fibrillation Quality of Life (AFEQT)
Временное ограничение: From baseline to 6 months PRIMARY ENDPOINT
|
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
|
From baseline to 6 months PRIMARY ENDPOINT
|
|
The Atrial Fibrillation Quality of Life (AFEQT)
Временное ограничение: From baseline to 12 weeks
|
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
|
From baseline to 12 weeks
|
|
The Atrial Fibrillation Quality of Life (AFEQT)
Временное ограничение: From baseline to 9 months
|
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
|
From baseline to 9 months
|
|
The Atrial Fibrillation Quality of Life (AFEQT)
Временное ограничение: From baseline to 15 months
|
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
|
From baseline to 15 months
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Electrocardiography (ECG) measurement
Временное ограничение: From baseline to 12 weeks
|
Change in symptomatic burden.
The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
|
From baseline to 12 weeks
|
|
ECG measurement
Временное ограничение: From baseline to 6 months
|
Change in symptomatic burden.
The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
|
From baseline to 6 months
|
|
ECG measurement
Временное ограничение: From baseline to 15 months
|
Change in symptomatic burden.
The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
|
From baseline to 15 months
|
|
Cardiac Anxiety Questionary (CAQ)
Временное ограничение: From baseline to 12 weeks
|
Symptom preoccupation
|
From baseline to 12 weeks
|
|
Cardiac Anxiety Questionary (CAQ)
Временное ограничение: From baseline to 6 months
|
Symptom preoccupation
|
From baseline to 6 months
|
|
Cardiac Anxiety Questionary (CAQ)
Временное ограничение: From baseline to 9 months
|
Symptom preoccupation
|
From baseline to 9 months
|
|
Cardiac Anxiety Questionary (CAQ)
Временное ограничение: From baseline to 15 months
|
Symptom preoccupation
|
From baseline to 15 months
|
|
the World Health Organization Disability Assessment Schedule (WHODAS 2.0, 12- item version)
Временное ограничение: From baseline to 12 weeks
|
General quality of life
|
From baseline to 12 weeks
|
|
WHODAS 2.0 (12-item version)
Временное ограничение: From baseline to 6 months
|
General quality of life
|
From baseline to 6 months
|
|
WHODAS 2.0 (12-item version)
Временное ограничение: From baseline to 15 months
|
General quality of life
|
From baseline to 15 months
|
|
Symptom checklist Severity and Frequency Scale (SCL)
Временное ограничение: From baseline to 12 weeks
|
AF related symptoms
|
From baseline to 12 weeks
|
|
Symptom checklist Severity and Frequency Scale (SCL)
Временное ограничение: From baseline to 6 months
|
AF related symptoms
|
From baseline to 6 months
|
|
Symptom checklist Severity and Frequency Scale (SCL)
Временное ограничение: From baseline to 15 months
|
AF related symptoms
|
From baseline to 15 months
|
|
Atrial Fibrillation Severity Scale
Временное ограничение: From baseline to 12 weeks
|
Symptomatic burden
|
From baseline to 12 weeks
|
|
Atrial Fibrillation Severity Scale
Временное ограничение: From baseline to 6 months
|
Symptomatic burden
|
From baseline to 6 months
|
|
Atrial Fibrillation Severity Scale
Временное ограничение: From baseline to 15 months
|
Symptomatic burden
|
From baseline to 15 months
|
|
Patient Health Questionnaire (PHQ-9)
Временное ограничение: From baseline to 12 weeks
|
Depression
|
From baseline to 12 weeks
|
|
PHQ-9
Временное ограничение: From baseline to 6 months
|
Depression
|
From baseline to 6 months
|
|
PHQ-9
Временное ограничение: From baseline to 15 months
|
Depression
|
From baseline to 15 months
|
|
Client satisfaction Questionnaire
Временное ограничение: From baseline to 12 weeks
|
Treatment satisfaction
|
From baseline to 12 weeks
|
|
Adverse events
Временное ограничение: From baseline to 12 weeks
|
Potential adverse reactions to the treatment
|
From baseline to 12 weeks
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Self-rated health, 1 item
Временное ограничение: From baseline to 12 weeks
|
The measure consists of a single item that asks the participants to rate their overall health as excellent, good, fair, or poor.
|
From baseline to 12 weeks
|
|
Self-rated health, 1 item
Временное ограничение: From baseline to 6 months
|
The measure consists of a single item that asks the participants to rate their overall health as excellent, good, fair, or poor.
|
From baseline to 6 months
|
|
Self-rated health, 1 item
Временное ограничение: From baseline to 15 months
|
The measure consists of a single item that asks the participants to rate their overall health as excellent, good, fair, or poor.
|
From baseline to 15 months
|
|
Healthcare consumption and work loss:Tic-P
Временное ограничение: From baseline to 12 weeks
|
The Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry assesses societal cost during the last month.
These costs include the participant's health care consumption (direct medical costs), time spent in other health promoting activities (direct non-medical costs), and sick leave, unemployment, and reduced work capacity at work and in the domestic realm (indirect non-medical costs).
|
From baseline to 12 weeks
|
|
Healthcare consumption and work loss:Tic-P
Временное ограничение: From baseline to 6 months
|
The Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry assesses societal cost during the last month.
These costs include the participant's health care consumption (direct medical costs), time spent in other health promoting activities (direct non-medical costs), and sick leave, unemployment, and reduced work capacity at work and in the domestic realm (indirect non-medical costs).
|
From baseline to 6 months
|
|
Healthcare consumption and work loss:Tic-P
Временное ограничение: From baseline to 15 months
|
The Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry assesses societal cost during the last month.
These costs include the participant's health care consumption (direct medical costs), time spent in other health promoting activities (direct non-medical costs), and sick leave, unemployment, and reduced work capacity at work and in the domestic realm (indirect non-medical costs).
|
From baseline to 15 months
|
|
The International Physical Activity Questionnaire
Временное ограничение: From baseline to 6 months
|
Physical activity
|
From baseline to 6 months
|
|
The International Physical Activity Questionnaire
Временное ограничение: From baseline to 12 weeks
|
Physical activity
|
From baseline to 12 weeks
|
|
The International Physical Activity Questionnaire
Временное ограничение: From baseline to 9 months
|
Physical activity
|
From baseline to 9 months
|
|
The International Physical Activity Questionnaire
Временное ограничение: From baseline to 15 months
|
Physical activity
|
From baseline to 15 months
|
|
Body Sensation Questionnaire
Временное ограничение: From baseline to 12 weeks
|
Fear of bodily sensations
|
From baseline to 12 weeks
|
|
Body Sensation Questionnaire
Временное ограничение: From baseline to 6 months
|
Fear of bodily sensations
|
From baseline to 6 months
|
|
Body Sensation Questionnaire
Временное ограничение: From baseline to 15 months
|
Fear of bodily sensations
|
From baseline to 15 months
|
|
Anxiety Sensitivity Index
Временное ограничение: From baseline to 12 weeks
|
Anxiety sensitivity
|
From baseline to 12 weeks
|
|
Anxiety Sensitivity Index
Временное ограничение: From baseline to 6 months
|
Anxiety sensitivity
|
From baseline to 6 months
|
|
Anxiety Sensitivity Index
Временное ограничение: From baseline to 15 months
|
Anxiety sensitivity
|
From baseline to 15 months
|
|
Accelerometer
Временное ограничение: From baseline to 12 weeks
|
Objective measurement of physical activity 1 week
|
From baseline to 12 weeks
|
|
Accelerometer
Временное ограничение: From baseline to 6 months
|
Objective measurement of physical activity 1 week
|
From baseline to 6 months
|
|
Accelerometer
Временное ограничение: From baseline to 15 months
|
Objective measurement of physical activity 1 week
|
From baseline to 15 months
|
|
Perceived stress scale (4-item version)
Временное ограничение: From baseline to 12 weeks
|
Stress reactivity
|
From baseline to 12 weeks
|
|
Perceived stress scale (4-item version)
Временное ограничение: From baseline to 6 months
|
Stress reactivity
|
From baseline to 6 months
|
|
Perceived stress scale (4-item version)
Временное ограничение: From baseline to 9 months
|
Stress reactivity
|
From baseline to 9 months
|
|
Perceived stress scale (4-item version)
Временное ограничение: From baseline to 15 months
|
Stress reactivity
|
From baseline to 15 months
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Спонсор
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования (Действительный)
8 января 2018 г.
Первичное завершение (Действительный)
20 декабря 2019 г.
Завершение исследования (Действительный)
20 сентября 2020 г.
Даты регистрации исследования
Первый отправленный
11 декабря 2017 г.
Впервые представлено, что соответствует критериям контроля качества
18 декабря 2017 г.
Первый опубликованный (Действительный)
19 декабря 2017 г.
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
23 сентября 2020 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
21 сентября 2020 г.
Последняя проверка
1 сентября 2020 г.
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- AF RCT 1
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Нет
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Нет
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Нет
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .